Skip to main content
. 2022 Oct 21;65(21):14864–14890. doi: 10.1021/acs.jmedchem.2c01414

Table 5. Kinetics of Binding for Synthetic Adenosine and NECA Phenoxycyclopentyl Derivatives to the Orthosteric Binding Site at Human and Rat A1R.

graphic file with name jm2c01414_0014.jpg

compd R1 R2 hA1R
rA1R
kon (k3) ×105 (M–1 min–1)a koff (k4) (min–1)b pKdc RT (min)d kon (k3) ×105 (M–1 min–1)a koff (k4) (min–1)b pKdc RT (min)d
24 –CH2OH H 4.78 ± 0.93 0.048 ± 0.004 6.97 ± 0.06 21.56 ± 2.13 2.70 ± 0.34 0.053 ± 0.001 6.70 ± 0.06 18.91 ± 0.30
25 –CH2OH p-t-Bu 1.48 ± 0.04 0.054 ± 0.005 6.44 ± 0.03 19.12 ± 2.01 4.84 ± 0.37 0.484 ± 0.173 6.17 ± 0.30 5.53 ± 3.31
26 –CH2OH m-OMe 2.97 ± 0.27 0.037 ± 0.003 6.90 ± 0.01 27.61 ± 2.09 3.32 ± 0.52 0.085 ± 0.007 6.58 ± 0.03 12.06 ± 1.03
27 –CH2OH m-Br 10.12 ± 1.29 0.038 ± 0.012 7.47 ± 0.09 33.13 ± 10.40 13.30 ± 1.21 0.050 ± 0.005 7.42 ± 0.03 20.40 ± 1.86
28 –CH2OH o-Cl 11.61 ± 1.31 0.052 ± 0.004 7.34 ± 0.04 19.55 ± 1.48 17.92 ± 1.30 0.048 ± 0.005 7.58 ± 0.01 21.46 ± 2.08
29 –CH2OH m-Cl 25.90 ± 2.14 0.040 ± 0.003 7.81 ± 0.02 25.37 ± 1.70 30.07 ± 4.02 0.071 ± 0.010 7.63 ± 0.12 15.20 ± 2.50
30 –CH2OH p-Cl 1.01 ± 0.31 0.056 ± 0.009 6.22 ± 0.13 19.46 ± 3.34 2.51 ± 0.90 0.056 ± 0.001 6.58 ± 0.15 17.90 ± 0.25
49 –CONHEt H 16.43 ± 2.81 0.028 ± 0.002 7.63 ± 0.01 32.82 ± 1.02 25.12 ± 2.08 0.037 ± 0.002 7.83 ± 0.05 27.61 ± 1.66
50 –CONHEt p-t-Bu 1.53 ± 0.11 0.091 ± 0.010 6.23 ± 0.06 11.47 ± 1.48 6.29 ± 0.62 0.070 ± 0.007 6.95 ± 0.01 14.76 ± 1.64
51 –CONHEt m-OMe 4.27 ± 0.03 0.027 ± 0.007 7.23 ± 0.11 42.68 ± 10.88 11.91 ± 1.33 0.030 ± 0.006 7.62 ± 0.11 38.05 ± 8.74
52 –CONHEt m-Br 5.57 ± 2.56 0.075 ± 0.038 6.91 ± 0.04 27.87 ± 14.23 4.46 ± 1.28 0.056 ± 0.008 6.85 ± 0.13 19.17 ± 2.68
53 –CONHEt o-Cl 17.27 ± 1.12 0.041 ± 0.010 7.66 ± 0.11 29.44 ± 6.91 37.59 ± 1.91 0.048 ± 0.003 7.90 ± 0.00 21.23 ± 1.22
54 –CONHEt m-Cl 20.28 ± 1.11 0.043 ± 0.013 7.75 ± 0.16 34.70 ± 13.43 35.85 ± 3.95 0.062 ± 0.007 7.76 ± 0.10 16.78 ± 2.22
55 –CONHEt p-Cl 3.75 ± 1.04 0.076 ± 0.024 6.71 ± 0.03 17.48 ± 4.79 11.62 ± 0.26 0.064 ± 0.003 7.26 ± 0.01 15.65 ± 0.78
a

kon (k3) for ligands as determined using NanoBRET binding assays using either human or rat Nluc-A1R expressing HEK 293 cells and determined through fitting with the ″kinetics of competitive binding″ model.35

b

koff (k4) for ligands determined as in footnote a.

c

Kinetic dissociation constant (pKd) for each ligand as determined from koff/kon.

d

Residence time of each ligand as determined by the reciprocal of the koff. All data are the mean ± SEM of at least three independent repeats conducted in duplicate.